Could Ozempic curb violence? A new study suggests GLP-1 drugs may weaken the link between impulsivity and aggressive behavior ...

Adults who started taking GLP-1 receptor agonist drugs such as semaglutide logged fewer daily steps and less time exercising ...

Millions of people taking semaglutide or tirzepatide for weight loss could be losing more than fat. A pharmacovigilance study ...

Harvard economist Rebecca Diamond found weight loss on GLP-1 drugs like Ozempic improved women's prospects of getting hired ...

A new drug could help people taking GLP-1 obesity drugs avoid muscle loss that often accompanies rapid weight loss.

New research finds GLP-1 users significantly reduced physical activity, with daily steps and exercise declining after ...

People with type 2 diabetes treated with semaglutide (Ozempic/Wegovy) had a 15% lower risk of bone fractures, according to findings presented Sunday at the Endocrine Society’s annual meeting in ...

GLP-1 meds could be stifling your senses. The drugs, originally developed to manage diabetes, have exploded in use after ...

New research finds that rates of GLP-1 use and misuse are shockingly high among people with a history of eating disorders.

After years of research, we finally understand how GLP-1s impact T on day 1 versus years later.

Ozempic is often described as a long-term medication by health care providers. It is FDA-approved to help adults with type 2 diabetes manage their blood sugar and, in certain pati ...